vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v11i6.488vsp-398Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWМИГРЕНЬ И ГОЛОВНАЯ БОЛЬ НАПРЯЖЕНИЯ У ДЕТЕЙ: ОСНОВНЫЕ ПОДХОДЫ К ЭФФЕКТИВНОЙ ТЕРАПИИ. ЧАСТЬ 2MIGRAINE AND TENSION-TYPE HEADACHE IN CHILDREN: THE APPROACH TO EFFECTIVE TREATMENT. PART 2СергеевА. В.SergeevA. V.sergeev.amd@gmail.comПервый Московский государственный медицинский университет им. И.М. СеченоваРоссияI.M. Sechenov First State Medical UniversityRussian Federation201219112012116Вопросы современной педиатрии2125Copyright © Сергеев А.В., 20122012Сергеев А.В.Sergeev A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/398

Детским неврологам часто приходится использовать не одобренные для применения в педиатрической практике лекарственные средства, индивидуально взвешивая возможную пользу и риск развития нежелательных лекарственных реакций. Мультидисциплинарный подход к терапии мигрени и головной боли напряжения, включающий коррекцию коморбидной психиатрической и соматической патологии, является ключом к снижению частоты и интенсивности головных болей и нормализации повседневной активности ребенка. Во второй части статьи обсуждаются вопросы симптоматической (эпизодический прием препаратов с целью купирования приступа боли) и профилактической (регулярное, длительное лечение, направленное на снижение частоты и интенсивности болевых приступов) фармакотерапии мигрени и головных болей напряжения в педиатрической практике.

Pediatric neurologists often have to prescribe drugs off-label in children, according to individual approach to every patient and weighing possible benefits and risk of side-effects. Multidisciplinary approach to migraine and tension-type headache treatment in children, including correction of comorbid psychiatric and somatic disorders, is a critical point in decrease of frequency and severity of headaches and normalization of everyday children’s activity. In the second part of the article the authors discuss the problems of symptomatic (episodic drugs taking in order to arrest a headache attack) and preventive (regular prolonged drug taking directed on decrease of frequency and severity of headaches) medical treatment of migraine and tension-type headaches in pediatric practice.

детимигреньголовная боль напряжениясимптоматическая терапияпрофилактическое лечениеchildrenmigrainetension-type headachesymptomatic treatmentpreventive treatmentReferencesСкоробогатых К. В., Азимова Ю. Э., Сергеев А. В., Осипова В. В., Табеева Г. Р. Обозрение материалов 15-го конгресса Междунар. общества головной боли, Берлин, 22–26 июня 2011 г. Рос. журн. боли. 2011; 3–4 (32–33): 67–70.Скоробогатых К. В., Азимова Ю. Э., Сергеев А. В., Осипова В. В., Табеева Г. Р. Обозрение материалов 15-го конгресса Междунар. общества головной боли, Берлин, 22–26 июня 2011 г. Рос. журн. боли. 2011; 3–4 (32–33): 67–70.Lewis D., Ashwal S., Hershey A. et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004; 63: 2215–2224.Lewis D., Ashwal S., Hershey A. et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004; 63: 2215–2224.Lewis D., Diamond S., Scott D. Prophylactic treatment of pediatric migraine. Headache. 2004; 44: 230–237.Lewis D., Diamond S., Scott D. Prophylactic treatment of pediatric migraine. Headache. 2004; 44: 230–237.Lewis D. Pediatric migraine. Neurol. Clin. 2009; 27 (2): 481–501.Lewis D. Pediatric migraine. Neurol. Clin. 2009; 27 (2): 481–501.Termine C., Ozge A., Antonaci F., Natriashvili S., Guidetti V., Wober-Bingol C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J. Headache Pain. 2011; 12 (1): 25–34.Termine C., Ozge A., Antonaci F., Natriashvili S., Guidetti V., Wober-Bingol C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J. Headache Pain. 2011; 12 (1): 25–34.Lewis D., Kellstein D., Burke B. et al. Children’s ibuprofen suspension for the acute treatment of migraine headache. Headache. 2002; 42: 780–786.Lewis D., Kellstein D., Burke B. et al. Children’s ibuprofen suspension for the acute treatment of migraine headache. Headache. 2002; 42: 780–786.Hamalainen M. L., Hoppu K., Valkeila E. et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997; 48: 102–107.Hamalainen M. L., Hoppu K., Valkeila E. et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997; 48: 102–107.Ahonen K., Hamalainen M. L., Rantala H., Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology. 2004; 62: 883–887.Ahonen K., Hamalainen M. L., Rantala H., Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology. 2004; 62: 883–887.Ueberall M. A. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999; 52: 1507–10.Ueberall M. A. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999; 52: 1507–10.Winner P., Lewis D., Hershey A. et al. Unique study design demonstrates that zolmitriptan 5 mg nasal spray is effective and well tolerated in the acute treatment of adolescent migraine. Headache 2005: Late breaking platform presentation at the June American Headache Society meeting in Philadelphia. 2005.Winner P., Lewis D., Hershey A. et al. Unique study design demonstrates that zolmitriptan 5 mg nasal spray is effective and well tolerated in the acute treatment of adolescent migraine. Headache 2005: Late breaking platform presentation at the June American Headache Society meeting in Philadelphia. 2005.Loder E., Burch R., Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012; 52 (6): 930–945.Loder E., Burch R., Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012; 52 (6): 930–945.Rothner A., Guo Y. An analysis of headache types, over-the counter (OTC) medication overuse and school absences in a pediatric/adolescent headache clinic. Headache. 2004; 44: 490.Rothner A., Guo Y. An analysis of headache types, over-the counter (OTC) medication overuse and school absences in a pediatric/adolescent headache clinic. Headache. 2004; 44: 490.Hershey A. D., Powers S. W., Bentti A. L., de Grauw T. J. Effec ti veness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000; 40: 539–549.Hershey A. D., Powers S. W., Bentti A. L., de Grauw T. J. Effec ti veness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000; 40: 539–549.Hershey A. D., Powers S. W., Vockell A. L. et al. Effectiveness of topiramate in the prevention of childhood headache. Headache. 2002; 42: 810–818.Hershey A. D., Powers S. W., Vockell A. L. et al. Effectiveness of topiramate in the prevention of childhood headache. Headache. 2002; 42: 810–818.Storey J. R., Calder C. S., Hart D. E., Potter D. L. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001; 41: 968–975.Storey J. R., Calder C. S., Hart D. E., Potter D. L. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001; 41: 968–975.Winner P., Pearlman E., Linder S. et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebocontrolled trial. Headache. 2005; 45: 1304–1312.Winner P., Pearlman E., Linder S. et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebocontrolled trial. Headache. 2005; 45: 1304–1312.Caruso J. M., Brown W. D., Exil G., Gascon G. G. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache. 2000; 40: 672–676.Caruso J. M., Brown W. D., Exil G., Gascon G. G. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache. 2000; 40: 672–676.Serdaroglu G., Erhan E., Tekgul H. et al. Sodium valproate prophylaxis in childhood migraine. Headache. 2002; 42: 819–822.Serdaroglu G., Erhan E., Tekgul H. et al. Sodium valproate prophylaxis in childhood migraine. Headache. 2002; 42: 819–822.Guidetti V., Moscato D., Ottaviano S. et al. Flunarizine and migraine in childhood an evaluation of endocrine function. Cephalalgia. 1987; 7: 263–266.Guidetti V., Moscato D., Ottaviano S. et al. Flunarizine and migraine in childhood an evaluation of endocrine function. Cephalalgia. 1987; 7: 263–266.Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta. Neurol. 1974; 50: 109–115.Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta. Neurol. 1974; 50: 109–115.Olness K., MacDonald J. T., Uden D. L. Comparison of self hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987; 79: 593–597.Olness K., MacDonald J. T., Uden D. L. Comparison of self hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987; 79: 593–597.Рачин А. П., Сергеев А. В., Авдеева Т. Г. Головная боль у детей (лекция). Проблемы амбулаторно-поликлинической педиатрии: Мат-лы Всеросс. семин. Москва–Смоленск. 2007. С. 147–177.Рачин А. П., Сергеев А. В., Авдеева Т. Г. Головная боль у детей (лекция). Проблемы амбулаторно-поликлинической педиатрии: Мат-лы Всеросс. семин. Москва–Смоленск. 2007. С. 147–177.Belman A. L., Milazo M., Savatic M. Gabapentin for migraine prophylaxis in children. Ann. Neurol. 2001; 50 (1): 109.Belman A. L., Milazo M., Savatic M. Gabapentin for migraine prophylaxis in children. Ann. Neurol. 2001; 50 (1): 109.Miller G. S. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004; 44: 238–243.Miller G. S. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004; 44: 238–243.Andrasik F., Grazzi L., Usai S. et al. Brief neurologist administered behavioral treatment of pediatric episodic tension-type headache. Neurology. 2003; 60: 1215–1216.Andrasik F., Grazzi L., Usai S. et al. Brief neurologist administered behavioral treatment of pediatric episodic tension-type headache. Neurology. 2003; 60: 1215–1216.Bussone G., Grazzi L., D’Amical D. et al. Biofeedback assisted relaxation training for young adolescents with tension-type headache. Cephalalgia. 1998; 18: 463–467.Bussone G., Grazzi L., D’Amical D. et al. Biofeedback assisted relaxation training for young adolescents with tension-type headache. Cephalalgia. 1998; 18: 463–467.Grazzi L., Andrasik F., Usai S. et al. Pharmacological behavioral treatment for children and adolescents with tension-type headache. Neurol. Sci. 2004; 25 (3): 270–271.Grazzi L., Andrasik F., Usai S. et al. Pharmacological behavioral treatment for children and adolescents with tension-type headache. Neurol. Sci. 2004; 25 (3): 270–271.Anttila P., Sourander A., Metsahonkala L., Aromaa M., Hele nius H., Sillanpaa M. Psychiatric symptoms in children with primary headache. J. Am. Acad. Child. Adolesc. Psychiatry. 2004; 43: 412–419.Anttila P., Sourander A., Metsahonkala L., Aromaa M., Hele nius H., Sillanpaa M. Psychiatric symptoms in children with primary headache. J. Am. Acad. Child. Adolesc. Psychiatry. 2004; 43: 412–419.Fearon P., Hotopf M. Relation between headache in childhood and physical and psychiatric symptoms in adulthood: national birth cohort study. BMJ. 2001; 322 (7295): 1145.Fearon P., Hotopf M. Relation between headache in childhood and physical and psychiatric symptoms in adulthood: national birth cohort study. BMJ. 2001; 322 (7295): 1145.

The authors declare that there are no conflicts of interest present.